Keros Plummets 73% After Unexpected Side Effects ‘Shock’ Its Lead DrugAuthorPosted byPublishedDecember 12, 20249:18 pmX (Twitter)FacebookLinkedInShare this postShare this postClose sharing boxKeros Plummets 73% After Unexpected Side Effects ‘Shock’ Its Lead DrugX (Twitter)FacebookLinkedInPosted by on December 12, 2024. Keros Therapeutics stock plummeted Thursday after the company stopped giving higher doses in a lung disease study due to side effects. Post Views: 29
Fulwell CEO Leo Pearlman Deletes LinkedIn Post Claiming Al Jazeera Reporter Killed By Israel Was Terrorist “Masquerading” As Journalist
Baldur’s Gate 3 publishing director says Stalker 2 had to “come out the oven” eventually, even if it did launch with a lot of bugs: “It’s just how it goes”
